NCT01375387View on ClinicalTrials.gov

Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

Lacosamide

100 mg oral tablet, single dose

DRUG

Lacosamide

Lacosamide 2 X 100 mg tablet

DRUG

Lacosamide

Lacosamide 4 X 100mg tablet

OTHER

Placebo 3

Placebo - 3 tablets

OTHER

Placebo 4

Placebo - 4 tablets

OTHER

Placebo 2

Placebo - 2 tablets

Trial Locations (1)

Unknown

Neuss

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT01375387 - Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males | Biotech Hunter | Biotech Hunter